phentermine has been researched along with Lung Diseases in 9 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
Lung Diseases: Pathological processes involving any part of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Additional studies are needed to determine the effects of chronic administration of amphetamines on circulating 5-HT." | 1.33 | Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. ( Baumann, MH; Rothman, RB; Zolkowska, D, 2006) |
| "The observed lung phospholipidosis was accompanied by inhibition of phospholipase C activity." | 1.27 | Role of phospholipase C in chlorphentermine-induced pulmonary phospholipidosis in rat. ( Kacew, S, 1988) |
| "Initially the phospholipidosis is localized largely in the AMs with the disorder developing in other compartments of the lungs with increasing treatment time." | 1.27 | Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels. ( Heyneman, CA; Reasor, MJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zolkowska, D | 1 |
| Rothman, RB | 1 |
| Baumann, MH | 1 |
| Kacew, S | 3 |
| Gairola, C | 1 |
| Matulionis, DH | 1 |
| Reasor, MJ | 4 |
| Thoma-Laurie, D | 1 |
| Walker, ER | 1 |
| Narbaitz, R | 1 |
| Ruddick, JA | 1 |
| Villeneuve, DC | 1 |
| Heyneman, CA | 2 |
| Smith, P | 1 |
| Heath, D | 1 |
| Hasleton, P | 1 |
9 other studies available for phentermine and Lung Diseases
| Article | Year |
|---|---|
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
Topics: Amphetamines; Animals; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relations | 2006 |
Role of age in amphiphilic drug-induced pulmonary morphological and metabolic responses.
Topics: Aging; Animals; Chlorphentermine; Glycogen; Lung; Lung Diseases; Organ Size; Phentermine; Phospholip | 1984 |
Chlorphentermine-induced alterations in the lungs of vitamin E-deficient and supplemented rats: 1. Biochemical and morphometric analysis of the pulmonary response.
Topics: Animals; Chlorphentermine; Foam Cells; Hemolysis; Lipid Peroxides; Lipidoses; Lung; Lung Diseases; M | 1983 |
Neonatal toxicity in rats following in utero exposure to chlorphentermine or phentermine.
Topics: Animals; Animals, Newborn; Body Weight; Chlorphentermine; Female; Lung; Lung Diseases; Maternal-Feta | 1982 |
Role of drug metabolism in protection against chlorphentermine-induced pulmonary phospholipidosis in adult rat.
Topics: Aminopyrine N-Demethylase; Aniline Hydroxylase; Animals; Body Weight; Chlorphentermine; Cytochrome P | 1981 |
Role of phospholipase C in chlorphentermine-induced pulmonary phospholipidosis in rat.
Topics: Alkaline Phosphatase; Animals; Chlorphentermine; Lipidoses; Lung; Lung Diseases; Male; Phentermine; | 1988 |
Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels.
Topics: Animals; Chlorphentermine; Lipidoses; Lung Diseases; Macrophages; Male; Phentermine; Phospholipids; | 1986 |
Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro.
Topics: Animals; Biological Transport; Chlorphentermine; In Vitro Techniques; Kinetics; Lipidoses; Lung Dise | 1986 |
Effects of prolonged administration of chlorphentermine on the rat lung.
Topics: Animals; Chlorphentermine; Histiocytes; Inflammation; Lung; Lung Diseases; Male; Microscopy, Electro | 1974 |